InvestorsHub Logo
Post# of 252254
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: biotech jim post# 141068

Tuesday, 05/01/2012 8:56:17 AM

Tuesday, May 01, 2012 8:56:17 AM

Post# of 252254
Suvorexant profile looks suitable for chronic use and I assume its side effect data are better due to its shorter t½ than that of the now discontinued almorexant from GSK/Actelion.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.